Literature DB >> 9462219

The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis.

B Rau1, G Steinbach, F Gansauge, J M Mayer, A Grünert, H G Beger.   

Abstract

BACKGROUND: Infection of pancreatic necrosis has a major impact on clinical course, management, and outcome in acute pancreatitis. Currently, guided fine needle aspiration is the only means for an early and accurate diagnosis of infected necrosis. Procalcitonin (PCT), a 116 amino acid propeptide of calcitonin, and interleukin 8 (IL-8), a strong neutrophil activating cytokine, are markers of severe inflammation and sepsis. AIMS: To analyse the clinical value of PCT and IL-8 as biochemical parameters for predicting infected necrosis in acute pancreatitis. PATIENTS AND METHODS: Fifty patients with acute pancreatitis entered this prospective study and were stratified into three groups according to morphological and bacteriological findings: 18 patients with oedematous pancreatitis (group I), 14 patients with sterile necrosis (group II), and 18 patients who developed infected necrosis a median of 13.5 days after the onset of symptoms (group III). After admission serum samples were drawn daily for two weeks. Concentrations of PCT and IL-8 were measured by chemoluminescent immunoassays (upper reference range 0.5 ng/ml for PCT and 70 pg/ml for IL-8). The routine parameter C-reactive protein was determined by laser nephelometry (upper reference range 10 mg/l).
RESULTS: Median concentrations of PCT and IL-8 were significantly higher in patients with infected necrosis than in those with sterile necrosis during the observation period, whereas there was no difference in C-reactive protein. In oedematous pancreatitis overall median concentrations of all three parameters were low. By receiver operating characteristics best cut off levels for predicting infected necrosis or persisting pancreatic sepsis were 1.8 ng/ml for PCT and 112 pg/ml for IL-8. If these cut off levels were reached on at least two days, sensitivity, specificity, and accuracy for the prediction of infected necrosis were 94%, 91%, and 92% for PCT and 72%, 75%, and 74% for IL-8, respectively. After surgical treatment of infected necrosis median PCT and IL-8 values continued to be significantly higher in patients with persisting pancreatic sepsis (n = 11) compared with those having an uneventful postoperative course (n = 7). For the preoperative differentiation between infected necrosis and sterile necrosis guided fine needle aspiration was performed in 24 patients with necrotising pancreatitis and reached a diagnostic accuracy of 84% compared with 87% for PCT, and 68% for IL-8. There was no correlation between the aetiology of acute pancreatitis or the extent of necrosis and PCT or IL-8.
CONCLUSION: PCT and IL-8 are found in high concentrations in infected necrosis and associated systemic complications in patients with acute pancreatitis. The course of PCT shows the closest correlation with the presence of infected necrosis. Monitoring of serum PCT is a potential new marker for the non-invasive and accurate prediction of infected necrosis as well as for the selection of patients with persisting septic complications after surgical debridement.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9462219      PMCID: PMC1891610          DOI: 10.1136/gut.41.6.832

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  28 in total

1.  The use of relative operating characteristic (ROC) curves in test performance evaluation.

Authors:  J R Beck; E K Shultz
Journal:  Arch Pathol Lab Med       Date:  1986-01       Impact factor: 5.534

2.  Fatal pancreatitis, a consequence of excessive leukocyte stimulation?

Authors:  H Rinderknecht
Journal:  Int J Pancreatol       Date:  1988-03

Review 3.  Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.

Authors:  M Baggiolini; A Walz; S L Kunkel
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

4.  Bacteriologic status of necrotic tissue in necrotizing pancreatitis.

Authors:  P A Banks; S G Gerzof; F K Chong; M G Worthington; W G Doos; J G Sullivan; W C Johnson
Journal:  Pancreas       Date:  1990-05       Impact factor: 3.327

Review 5.  Surgical treatment of infected necrosis.

Authors:  B Rau; W Uhl; M W Buchler; H G Beger
Journal:  World J Surg       Date:  1997-02       Impact factor: 3.352

6.  Bacterial contamination of pancreatic necrosis. A prospective clinical study.

Authors:  H G Beger; R Bittner; S Block; M Büchler
Journal:  Gastroenterology       Date:  1986-08       Impact factor: 22.682

7.  Early diagnosis of pancreatic infection by computed tomography-guided aspiration.

Authors:  S G Gerzof; P A Banks; A H Robbins; W C Johnson; S J Spechler; S M Wetzner; J M Snider; R E Langevin; M E Jay
Journal:  Gastroenterology       Date:  1987-12       Impact factor: 22.682

8.  Immunocytochemical localization of calcitonin in Kulchitsky cells of human lung.

Authors:  K L Becker; K G Monaghan; O L Silva
Journal:  Arch Pathol Lab Med       Date:  1980-04       Impact factor: 5.534

9.  Incidence of necrotizing pancreatitis and factors related to mortality.

Authors:  D B Allardyce
Journal:  Am J Surg       Date:  1987-09       Impact factor: 2.565

10.  Multiple-organ failure. Generalized autodestructive inflammation?

Authors:  R J Goris; T P te Boekhorst; J K Nuytinck; J S Gimbrère
Journal:  Arch Surg       Date:  1985-10
View more
  62 in total

1.  Diagnosis, objective assessment of severity, and management of acute pancreatitis. Santorini Consensus Conference.

Authors:  H G Beger; R Isenmann
Journal:  Int J Pancreatol       Date:  1999-08

2.  Monitoring procalcitonin is of value in acute pancreatitis.

Authors:  David Bihari
Journal:  BMJ       Date:  2004-07-24

3.  Soluble CD40 ligand in prediction of acute severe pancreatitis.

Authors:  Jean Louis Frossard; Philippe Morel; Brenda Kwak; Catherine Pastor; Thierry Berney; Léo Buhler; Alain Von Laufen; Sandrine Demulder; François Mach
Journal:  World J Gastroenterol       Date:  2006-03-14       Impact factor: 5.742

4.  Does serum procalcitonin have a role in evaluating the severity of acute pancreatitis? A question revisited.

Authors:  Sanjay Purkayastha; Andre Chow; Thanos Athanasiou; Apostolos Cambaroudis; Sukhmeet Panesar; James Kinross; Paris Tekkis; Ara Darzi
Journal:  World J Surg       Date:  2006-09       Impact factor: 3.352

5.  Immunosuppression in patients with severe acute pancreatitis.

Authors:  Takashi Ueda; Yoshifumi Takeyama; Takeo Yasuda; Makoto Shinzeki; Hidehiro Sawa; Takahiro Nakajima; Tetsuo Ajiki; Yasuhiro Fujino; Yasuyuki Suzuki; Yoshikazu Kuroda
Journal:  J Gastroenterol       Date:  2006-08       Impact factor: 7.527

Review 6.  Management of necrotizing pancreatitis.

Authors:  J Slavin; P Ghaneh; R Sutton; M Hartley; P Rowlands; C Garvey; M Hughes; J Neoptolemos
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

7.  Procalcitonin and acute coronary syndromes: a new biomarker for an old disease.

Authors:  Luigi M Biasucci; Gina Biasillo; Antonella Stefanelli
Journal:  Intern Emerg Med       Date:  2009-07-29       Impact factor: 3.397

8.  New approaches to sepsis: molecular diagnostics and biomarkers.

Authors:  Konrad Reinhart; Michael Bauer; Niels C Riedemann; Christiane S Hartog
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

Review 9.  Severe acute pancreatitis: Clinical course and management.

Authors:  Hans G Beger; Bettina M Rau
Journal:  World J Gastroenterol       Date:  2007-10-14       Impact factor: 5.742

Review 10.  Severe acute pancreatitis: pathogenetic aspects and prognostic factors.

Authors:  Ibrahim-A Al Mofleh
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.